Journal article
Barriers to routine G6PD testing prior to treatment with primaquine.
- Abstract:
-
Background
Primaquine is essential for the radical cure of vivax malaria, however its broad application is hindered by the risk of drug-induced haemolysis in individuals with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Rapid diagnostic tests capable of diagnosing G6PD deficiency are now available, but these are not used widely.
Methods
A series of qualitative interviews were conducted with policy makers and healthcare providers in four vivax-endemic count...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
ustralian Government Department of Foreign Affairs and Trade
More from this funder
Bill and Melinda Gates Foundation
More from this funder
US President’s Malaria Initiative
More from this funder
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- Malaria Journal Journal website
- Volume:
- 16
- Issue:
- 1
- Pages:
- 329
- Publication date:
- 2017-08-01
- Acceptance date:
- 2017-08-07
- DOI:
- EISSN:
-
1475-2875
- Pmid:
-
28797255
- Source identifiers:
-
724233
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:724233
- UUID:
-
uuid:688c5ba2-7a05-4127-8a77-fd9d4dd44166
- Local pid:
- pubs:724233
- Deposit date:
- 2017-08-25
Terms of use
- Copyright holder:
- Price et al
- Copyright date:
- 2017
- Notes:
- © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record